Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Going red. The usual.
Since LP sold/assigned 10% of the lawsuit claim,
I got the same innuendo from LG several months ago as I understood him, that they were going forward based on manual production. Automation will come later as it becomes ready for prime time. Of course things could be different several months later.
1) Up to date financial information given in an ASM or quarterly conference call is not illegal. Calling Dave and getting the information that isn’t public is illegal.
Any idea if Allan Butler is still alive or when he died?
Thank you very much.
I have a friend with pancreatic cancer. Does any one know how long he survived his DCVAX-Direct treatment back in 2014? I saw a video he put out that said he was still alive in 2018. Are there any other such good stories of those treated back then for pancreatic cancer in the PI back circa 3014. Does anyone have the chart they put of those various solid cancers they treated back then? Thanks for the help.
One piece of news is not enough. They have to produce more news consistently and talk of preparations so they can make PRs much more often. One news and then you stop gets you nowhere. the shorts have to know there will plenty of great news announcement about what is coming, not just what will come. One piece of news followed by silence till the next is a recipe inviting the shorts to do their best. They need to be concerned when that next PR will be out (and not just many months later.
They are now blazing their own path, a path no one else has taken, to get this treatment to market. NWBO continues to check off milestones as they come closer and closer to approval. This process isn't fast. Yet, management is doing exactly what they need to do to methodically check off the boxes towards RA approval(s).
before the April 3 deadline of the MAA submission,
I have been in a long time - from before 2013. But luckily the bulk of my holding was acquired around the lows later on. I still hold warrants at near the low that will not expire for a while. While I have been exhausted by the continued delays, adding steps, moving the goal posts, the changing of my expectations to times further out, but I now do believe we are truly near the end of all this with the MAA and MA that are both around the corner and could drop at any moment. The points I ponder the most at this time are, 1) will they only file in the UK for the MAA or will they go with some means of filing in multiple jurisdictions in parallel (eg ORBIS), 1a) it would be nice to know if they are doing a rolling submission, but we will know this fairly soon, 2) will they be able to file not only for glio (n & r), or will they try to use the notion of tissue and/or tumor agnostic, and file for multiple cancers at one time? Glio is a given in my book that just needs a little time to play out. 3) how the spoofing case proceeds and whether there will be a settlement in the short term or a trial in the long term. 4) Whether and when the spoofing trial will be expanded to include naked short selling and other manipulations, and 5) what is happening on the BO or partnership fronts, 6) when we eventually uplist, but this is low on the totem pole of concerns.
but Tissue agnostic ain’t happening.
I do not click on any site that requires me to accept cookies in order to read their webpage.
but there have been too many changes of story
All I know is from this BB. That seems to be the assumption on the BB, but I have no proof of that. I would really like to know that with more certainty.
Not likely the case if the law firm took the case on a contingency basis, They only get any money if they actually get money from the defendants. They are not in it "simply to distract the MMs" as a favour to NWBO.
Senti, this has nothing to do with being "nice." I am sure it is a hardnosed expert assessment by Cohen Milstein that there is a lot of money to made here by the law firm in either a reasonably quick settlement or a larger payday in eventual success at trial.
Why rehash losing arguments? Even a kid will tell you, that is probably not a very good plan for success. These lawyers are not stupid.
Thanks again.
So, how compelling are the MTDs?
Thank you for the info.
So now that the MTDs have been filed what is the next shoe to drop. Until when does NWBO have to respond to the MTDs? Then, is their a typical amount of time by when the judge usually rules, or is every case different? By then the defendants will have filed their replies to the complaint. So what next? I guess that is when we get into the discovery phase of the case or perhaps the settlement phase of the case. How long might it take until we actually get to trial on the merits? Lawyers, care to opine?
Does anyone know if the defense in the spoofing case filed anything today as per the deadline set by the judge?
this is pure speculation, but perhaps they were waiting to align the MIA news with the reply expected in the spoofing case on the 20th which will hopefully show how weak a case the defendants have.
Actually, I am surprised that this has not yet happened. It seems like easy money for large fees for a law firm with little to do as they just have to follow the Cohen game plan and use much of the same data that Cohen has already laid out. the heavy lifting has already been done.
I would love to see this as a class action on behalf of the NWBO shareholders. Hope a class action law firm is pointed in this direction soon!
The reality is they are not able to bring big investors that see the value of the ph 3 data as well as the progress they have made and importantly value the company over a $2-3B market cap.
Anyone following Dr M. Bosch?
Just got filled at $0.556
I just used that language as a shorthand for what actually happened. In the end it was a sale of Cognate! The new build out of Advent now suffers from the same perception of conflict of interest as Cognate suffered from, for which it was sold..
True. But you can’t convince bears of much of anything.
I never understood the logic in selling Cognate to CRL and then to start over with a build out of Advent to do the same all over again!
Much the same is true of any submission they make to the regulators, once something is turned over to them, the ball is totally in their court.
FDIC only covers $250,000 per account.
CNBC just reported that Roku had several hundred million on deposit at SVB. They do not know how much of that they will recover. Hope the $11 mil NWBO just borrowed is not on deposit at SVB. After all they are a MD headquarter - not in Silicon Valley..
CNBC has just related the big drop in the biotech sector today to the failure of SVB (many of whom bank there?)
Silicon Valley Bank went bust today - not sure if related in some indirect way
Silicon Valley Bank went bust today - not sure if related in some indirect way
David Innes probably is MIA.